Redox Signaling in Sickle Cell Disease

Area of Science:

• Biomedical Science
• Hematology
• Pathophysiology

Background:

• Sickle cell disease (SCD) causes chronic hemolysis and vascular occlusion, leading to organ damage.
• SCD exhibits an imbalance favoring pro-oxidant pathways over anti-oxidant processes at multiple biological levels.
• Oxidative stress is a key factor in SCD pathogenesis.

Purpose of the Study:

• To review new findings on the generation of oxidative stress in SCD.
• To highlight protective mechanisms against oxidative stress in SCD.
• To discuss the impact of antioxidant therapy in clinical trials for SCD.

Main Methods:

• Review of current literature on oxidative stress in sickle cell disease.
• Analysis of molecular and cellular mechanisms contributing to oxidative stress.
• Examination of protective factors and antioxidant therapies in human and murine models of SCD.

Main Results:

• Oxidized hemin, hemolysis, mitochondrial dysfunction, and the innate immune system contribute to oxidative stress in SCD.
• Hemopexin, haptoglobin, heme oxygenase-1 (HO-1), and Nrf2 are identified as potential protective factors.
• Recent clinical trials indicate beneficial effects of antioxidant therapy in SCD.

Conclusions:

• Oxidative stress is a critical component of sickle cell disease pathophysiology.
• Targeting pro-oxidant pathways and enhancing anti-oxidant defenses represent potential therapeutic strategies.
• Antioxidant therapies warrant further investigation for managing SCD and preventing organ injury.